Pharmaceutical

Govt weighs incorporating trade-margin rationalisation into DPCO

No deadline set for policy; non-scheduled drugs account for 82% of market, average channel markup on common dosage forms is 43%

'India began drug discovery before China, but China has moved years ahead'

India's pharma industry must pivot from global leadership in generics to innovation, backed by stronger policy, R&D funding and regulatory reforms, says Satish Reddy

International business to remain key driver for Emcure Pharma in FY27

Emcure expects overseas markets to drive growth in FY27 through product approvals, differentiated offerings and capacity expansion, while domestic business is seen improving

Zydus Life gets USFDA nod for generic indocyanine green for injection

USFDA has granted final approval to Zydus Lifesciences' generic version of IC-Green, an imaging agent used in vascular, transplant and cancer surgeries.

After sharp stock rally, valuation hurdles may cap Divi's returns

Strong custom synthesis growth, peptide opportunities and higher earnings estimates support Divi's outlook, but elevated valuations could restrict further stock upside

Divi's Labs rallies 5% on strong Q1; surpasses Eicher, Hindalco in mcap

In the past month, Divi's Labs outperformed the market by soaring 25 per cent, as against a 1.2 per cent rise in the BSE Sensex.

Mankind Pharma Q1 result: Profit rises 29.6% to ₹568 cr, revenue up 12.9%

Profit before tax rose 42.4 per cent to ₹769 crore as expenses grew slower than revenue and finance costs declined 35.6 per cent; tax expense more than doubled

Oriflame to sell India manufacturing operations to Akums subsidiary

The Swedish beauty brand will retain its commercial operations in India while entering a long-term manufacturing and supply partnership with Akums

Cadila Pharma says no curbs on Aciloc products, affirms compliance

Cadila Pharmaceuticals said Aciloc 150+ and Aciloc 300+ remain available without any restrictions on manufacture or sale, while reaffirming compliance with regulatory requirements

Emcure Pharma makes Gennova wholly owned, names Samit Mehta CEO

Restructuring positions biotech arm to focus on biologics and biosimilar

Indian drugmakers line up for Keytruda biosimilar race as patents near end

Biocon, Zydus, Dr Reddy's are among companies positioning for one of the largest biosimilar launches for cancer treatment

Indian pharma's next prescription: Specialty drugs, not just generics

Indian drugmakers are reducing reliance on US generics, turning to specialty medicines, biosimilars and emerging markets to drive sustainable growth

Cipla expands respiratory, specialty manufacturing across India, China, US

Filed 10 applications with USFDA in FY26 to build a pipeline of differentiated products for regulated markets

Beyond Zaynich: Wockhardt bets on WCK 6777 as next blockbuster jab

Once-a-day injectable antibiotic aimed at treatment beyond hospitals through outpatient centres

Govt considering extending duty relief on petrochemical imports beyond June

The exemption, announced earlier this year, covers 40 petrochemical products used for making plastics and pharmaceuticals and is currently valid through June 30

Panacea Biotec zooms 60% in 6 days; stock hits new high on huge volumes

In the past two months, the stock price of Panacea Biotec has skyrocketed 101 per cent.

Beyond GLP-1, Novo eyes next-gen obesity drugs: Vikrant Shrotriya

Novo Nordisk plans to defend its obesity drug leadership in India as semaglutide patent expiry fuels competition from nearly 50 new market entrants

Uttar Pradesh govt plans to develop pharma ecosystem over 8,000 acres

Uttar Pradesh plans an 8,000-acre healthcare manufacturing ecosystem to attract investments, boost exports and emerge as a major pharma hub

CDSCO directs drugmakers to maintain pharmacovigilance systems

The drug regulator has asked central and state authorities to verify compliance with pharmacovigilance requirements during routine inspections and regulatory reviews

Spirulina: A natural healthy food, billions of years old, gains traction

Spirulina can, indeed, prove a boon for a country like India where malnutrition, especially protein deficiency (anaemia), is rampant